Myths and misconceptions in small animal anesthesia

Journal of the American Veterinary Medical Association

Volumn 223, Issue 10, 2003, Pages 1426-1432

  Wagner, Ann E ^a   Wright, Bonnie D ^a   Hellyer, Peter W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; BENZODIAZEPINE; BUTORPHANOL; HALOTHANE; INFUSION FLUID; INHALATION ANESTHETIC AGENT; KETAMINE; LOCAL ANESTHETIC AGENT; MEDETOMIDINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGEN; PROPOFOL; SEVOFLURANE; THIOPENTAL; TRANQUILIZER; XYLAZINE;

ANESTHESIA; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANESTHETIC RECOVERY; ANIMAL BEHAVIOR; ANIMAL CARE; APNEA; BEHAVIOR DISORDER; BRADYCARDIA; CARDIOVASCULAR RESPONSE; DEFECATION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; ELECTROCARDIOGRAM; HEALTH CARE QUALITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART VENTRICLE ARRHYTHMIA; HYPERTENSION; HYPOTENSION; MORTALITY; NEUROTOXICITY; NONHUMAN; OXYGEN BREATHING; PAIN; PATIENT MONITORING; PATIENT SELECTION; PREMEDICATION; PULSE OXIMETER; PULSE RATE; RESPIRATION DEPRESSION; REVIEW; SPECIES DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; VAGUS NERVE STIMULATION; VETERINARY MEDICINE; VOMITING;

ANESTHESIA; ANESTHETICS, COMBINED; ANIMALS; ANIMALS, DOMESTIC; CATS; DOGS; PREANESTHETIC MEDICATION; SAFETY; TREATMENT OUTCOME;

ANIMALIA;

EID: 0242693104     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2003.223.1426     Document Type: Review

References (54)

1. Clarke KW, Hall LW. A survey of anaesthesia in small animal practice: AV/BSAVA report. J Assoc Vet Anaesth 1990;17:4-10.
2. Dodman NH, Lamb LA. Survey of small animal anesthetic practice in Vermont. J Am Anim Hosp Assoc 1992;28:439-445.
3. Dyson DH, Maxie MG. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc 1998;34:325-335.
4. Gaynor S, Dunlop CI, Wagner AE, et al. Complications and mortality associated with anesthesia in dogs and cats. J Am Anim Hosp Assoc 1999;35:13-17.
5. Sams RA, Muir WW, Detra RL, et al. Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. Am J Vet Res 1985;46:1677-1683.
6. Robinson EP, Sams RA, Muir WW. Barbiturate anesthesia in Greyhound and mixed-breed dogs: comparative cardiopulmonary effects, anesthetic effects, and recovery rates. Am J Vet Res 1986;47: 2105-2112.
7. Freye E. Cardiovascular effects of high dosages of fentanyl, meperidine, and naloxone in dogs. Anesth Analg 1974;53:40-47.
8. Steffey EP, Martucci R, Howland D, et al. Meperidine-halothane interaction in dogs. Can Anaesth Soc J 1977;24:459-467.
9. Stanley TH, Liu WS, Webster LR, et al. Haemodynamic effects of intravenous methadone anaesthesia in dogs. Can Anaesth Soc J 1980;27:52-57.
10. Murphy MR, Hug CC. The enflurane sparing effect of morphine, butorphanol, and nalbuphine. Anesthesiology 1982;57: 489-492.
11. Copland VS, Haskins SC, Patz J. Naloxone reversal of oxymorphone effects in dogs. Am J Vet Res 1989;50:1854-1858.
12. 2-adrenergic receptor antagonists. J Am Vet Med Assoc 1989;195:378-381.
13. Dyson DH, Doherty T, Anderson GI, et al. Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol. Vet Surg 1990;19:398-403.
14. Jacobson JD, McGrath CJ, Smith EP. Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs. Vet Surg 1994;23:299-306.
15. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Ability of flumazenil, butorphanol, and naloxone to reverse the anesthetic effects of oxymorphone-diazepam in dogs. J Am Vet Med Assoc 1996; 209:776-779.
16. Domitor and Antisedan [monograph]. Exton, Pa: Pfizer Animal Health, 1996.
17. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998;27: 612-622.
18. Watney GC, Pablo LS. Median effective dosage of propofol for induction of anesthesia in dogs. Am J Vet Res 1992;53:2320-2322.
19. Hellyer PW. Management of acute and surgical pain. Semin Vet Med Surg (Small Anim) 1997;12:106-114.
20. Hellyer PW, Gaynor JS. How I treat: acute postsurgical pain in dogs and cats. Compend Contin Educ Pract Vet 1998;20:140-153.
21. Mathews KA. Pain assessment and general approach to management. Vet Clin North Am Small Anim Pract 2000;30:729-755.
22. Nolan AM, Reid J. The use of intraoperative fentanyl in spontaneously breathing dogs undergoing orthopaedic surgery. J Vet Anaesth 1991;18:30-39.
23. Waterman AE, Kalthum W. Use of opioids in providing postoperative analgesia in the dog: a double-blind trial of pethidine, pentazocine, buprenorphine, and butorphanol. In: Short CE, Van Poznak A, ed. Animal pain. New York: Churchill Livingstone Inc, 1992;466-476.
24. Sawyer DC, Rech RH, Durham RA, et al. Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs. Am J Vet Res 1991;52:1826-1830.
25. Quandt JE, Raffe MR, Robinson EP. Butorphanol does not reduce the minimum alveolar concentration of halothane in dogs. Vet Anesth 1994;23:156-159.
26. Carroll GL, Howe LB, Slater MR, et al. Evaluation of analgesia provided by postoperative administration of butorphanol to cats undergoing onychectomy. J Am Vet Med Assoc 1998;213: 246-250.
27. Sawyer DC, Rech RH. Analgesia and behavioral effects of butorphanol, nalbuphine, and pentazocine in the cat. J Am Hosp Assoc 1987;23:438-446.
28. Yakaitis RW, Blitt CD, Aniulo JP. End-tidal halothane concentration for endotracheal intubation. Anesthesiology 1977;47: 386-388.
29. Haws JL, Herman N, Clark Y, et al. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998;86:208-213.
30. Turner DM, Ilkiw JE. Cardiovascular and respiratory effects of three rapidly acting barbiturates in dogs. Am J Vet Res 1990;51: 598-604.
31. + conductance of myocardium. J Pharmacol Exp Ther 1993;265:358-365.
32. Ilkiw JE, Haskins SC, Patz JD. Cardiovascular and respiratory effects of thiopental administration in hypovolemic dogs. Am J Vet Res 1991;52:576-580.
33. Branson KR. Injectable anesthetics. In: Adams HR, ed. Veterinary pharmacology and therapeutics. 8th ed. Ames, Iowa: Iowa State University Press, 2001;213-267.
34. Ilkiw JE. Injectable anesthesia in dogs - part 1: solutions, doses and administration. Available at: www.ivis.org/advances/ Anesthesia-Gleed/ilkiw/chapter frm.asp?LA=1. Accessed Feb 17, 2003.
35. Wagner AE, Hellyer PW. Survey of anesthesia techniques and concerns in private veterinary practice. J Am Vet Med Assoc 2000;217:1652-1657.
36. Schwartz DA, Horwitz LD. Effects of ketamine on left ventricular performance. J Pharmacol Exp Ther 1975;194:410-414.
37. Christ G, Mundigler G, Merhant C, et al. Adverse cardiovascular effects of ketamine infusion in patients with catecholaminedependent heart failure. Anesth Intensive Care 1997;25:255-259.
38. Heldmann E, Brown DC, Shofer F. The association of propofol usage with postoperative wound infection rate in clean wounds: a retrospective study. Vet Surg 1999;28:256-259.
39. Quandt JE, Robinson EP, Rivers WJ, et al. Cardiorespiratory and anesthetic effects of propofol and thiopental in dogs. Am J Vet Res 1998;59:1137-1143.
40. Mutoh T, Nishimura R, Kim HY, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 1997;58:885-890.
41. Muir WW, Gadawski J. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A. Am J Vet Res 1998;59:603-608.
42. Draper WB, Whitehead RW. The phenomenon of diffusion respiration. Anesth Analg 1947;28:307-318.
43. Blaze CA, Robinson NE. Apneic oxygenation in anesthetized ponies and horses. Vet Res Comm 1987;11:281-291.
44. Severinghaus JW, Kelleher JF. Recent developments in pulse oximetry. Anesthesiology 1992;76:1018-1038.
45. Mazzaferro E, Wagner AE. Hypotension during anesthesia in dogs and cats: recognition, causes, and treatment. Compend Contin Educ Pract Vet 2001;23:728-737.
46. Wagner AE, Hellyer PW. Observations of private veterinary practices in Colorado, with an emphasis on anesthesia. J Vet Med Educ 2002;29:175-182.
47. Grauer GF. Prevention of acute renal failure. Vet Clin North Am Small Anim Pract 1996;26:1447-1459.
48. Steffey EP. Other new and potentially useful inhalational anesthetics. Vet Clin North Am Small Anim Pract 1992;22:335-340.
49. Antognini JF, Wang XW, Carstens E. Quantitative and qualitative effects of isoflurane on movement occurring after noxious stimulation. Anesthesiology 1999;91:1064-1071.
50. Prys-Roberts C. Anaesthesia: a practical or impractical construct? Br J Anaesth 1987;59:1341-1345.
51. Zbinden AM, Maggiorini M, Petersen-Felix S, et al. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia, part I: motor reactions. Anesthesiology 1994;80:253-260.
52. Hansen BD, Hardie EM, Carroll GS. Physiological measurements after ovariohysterectomy in dogs: what's normal? Appl Anim Behav Sci 1997;51:101-109.
53. Hardie EM, Hansen BD, Carroll GS. Behavior after ovariohysterectomy in the dog: what's normal? Appl Anim Behav Sci 1997; 51:111-128.
54. Hansen B. Through a looking glass darkly: using behavior to assess pain. Semin Vet Med Surg (Small Anim) 1997;12:61-74.